Precision Optics Corporation (POCI) Net Income towards Common Stockholders (2010 - 2026)
Precision Optics Corporation (POCI) posted quarterly Net Income towards Common Stockholders of -$108283.0 for Q1 2026, up 94.84% year-over-year from -$55576.6 in Q1 2025, and up 93.92% quarter-over-quarter from -$1.8 million in Q4 2025.
Precision Optics Corporation (POCI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$108283.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 94.84% year-over-year to -$108283.0; the TTM figure through Mar 2026 stood at -$4.9 million (up 14.86% YoY), while the FY2025 annual figure was -$5.8 million, down 95.85% from the prior year.
- Net Income towards Common Stockholders rose to -$108283.0 in Q1 2026 per POCI's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $508668.0 in Q4 2022 and bottomed at -$2.1 million in Q1 2025.
- Historically, Net Income towards Common Stockholders has averaged -$720408.4 across 5 years, with a median of -$464415.0 in 2023.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 200.33% — and 2024, when it slumped 1367.99%.
- Precision Optics Corporation's Net Income towards Common Stockholders stood at $508668.0 in 2022, then tumbled by 249.17% to -$758802.0 in 2023, then slipped by 27.79% to -$969681.0 in 2024, then tumbled by 83.65% to -$1.8 million in 2025, then jumped by 93.92% to -$108283.0 in 2026.
- Business Quant data shows POCI's Net Income towards Common Stockholders at -$108283.0 in Q1 2026, -$1.8 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Precision Optics Corporation | 35.46 Mn | 24.78 Mn | 2.06 Mn | -108,283.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108,283.00 |
| Dec 31, 2025 | -1.78 Mn |
| Sep 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Dec 31, 2024 | -969,681.00 |
| Sep 30, 2024 | -1.31 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | -317,055.00 |
| Dec 31, 2023 | -758,802.00 |
| Sep 30, 2023 | -464,415.00 |
| Jun 30, 2023 | -96,125.00 |
| Mar 31, 2023 | -398,432.00 |
| Dec 31, 2022 | 508,668.00 |
| Sep 30, 2022 | -158,724.00 |
| Jun 30, 2022 | 269,297.00 |
| Mar 31, 2022 | -113,899.00 |
| Dec 31, 2021 | -507,013.00 |
| Sep 30, 2021 | -576,801.00 |
| Jun 30, 2021 | -442,452.00 |